Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.

MLA

Taguchi, Takahide, et al. “Concurrent Chemoradiotherapy with Cisplatin, 5-Fluorouracil, Methotrexate, and Leucovorin in Patients with Advanced Resectable Squamous Cell Carcinoma of the Larynx and Hypopharynx.” Acta Oto-Laryngologica, vol. 126, no. 4, Apr. 2006, pp. 408–13. EBSCOhost, https://doi.org/10.1080/00016480500401019.

APA

Taguchi, T., Tsukuda, M., Mikami, Y., Matsuda, H., Horiuchi, C., Yoshida, T., Nishimura, G., Ishitoya, J.-I., & Katori, H. (2006). Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Oto-Laryngologica, 126(4), 408–413. https://doi.org/10.1080/00016480500401019

Chicago

Taguchi, Takahide, Mamoru Tsukuda, Yasukazu Mikami, Hideki Matsuda, Choichi Horiuchi, Takafumi Yoshida, Goshi Nishimura, Jun-Ichi Ishitoya, and Hideaki Katori. 2006. “Concurrent Chemoradiotherapy with Cisplatin, 5-Fluorouracil, Methotrexate, and Leucovorin in Patients with Advanced Resectable Squamous Cell Carcinoma of the Larynx and Hypopharynx.” Acta Oto-Laryngologica 126 (4): 408–13. doi:10.1080/00016480500401019.